Prox1 maintains muscle structure and growth in the developing heart

  • Catherine A. Risebro
    Molecular Medicine Unit, UCL Institute of Child Health, London WC1N 1EH,UK.
  • Richelle G. Searles
    Molecular Medicine Unit, UCL Institute of Child Health, London WC1N 1EH,UK.
  • Athalie A. D. Melville
    Molecular Medicine Unit, UCL Institute of Child Health, London WC1N 1EH,UK.
  • Elisabeth Ehler
    The Randall Centre of Cell and Molecular Biophysics and The Cardiovascular Division, King's College, London SE1 1UL, UK.
  • Nipurna Jina
    Molecular Haematology and Cancer Biology Unit, UCL Institute of Child Health,London WC1N 1EH, UK.
  • Sonia Shah
    Bloomsbury Centre for Bioinformatics, Department of Computer Science,University College London, Gower Street, London WC1E 6BT, UK.
  • Jacky Pallas
    Bloomsbury Centre for Bioinformatics, Department of Computer Science,University College London, Gower Street, London WC1E 6BT, UK.
  • Mike Hubank
    Molecular Haematology and Cancer Biology Unit, UCL Institute of Child Health,London WC1N 1EH, UK.
  • Miriam Dillard
    Department of Genetics and Tumor Cell Biology, St Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA.
  • Natasha L. Harvey
    Division of Haematology, The Hanson Institute, Adelaide, South Australia 5000,Australia.
  • Robert J. Schwartz
    Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, TX 77030, USA.
  • Kenneth R. Chien
    Massachusetts General Hospital Cardiovascular Research Center, Boston, MA 02114, USA.
  • Guillermo Oliver
    Department of Genetics and Tumor Cell Biology, St Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, USA.
  • Paul R. Riley
    Molecular Medicine Unit, UCL Institute of Child Health, London WC1N 1EH,UK.

説明

<jats:p>Impaired cardiac muscle growth and aberrant myocyte arrangement underlie congenital heart disease and cardiomyopathy. We show that cardiac-specific inactivation of the murine homeobox transcription factor Prox1 results in the disruption of expression and localisation of sarcomeric proteins, gross myofibril disarray and growth-retarded hearts. Furthermore, we demonstrate that Prox1 is required for direct transcriptional regulation of the genes encoding the structural proteins α-actinin, N-RAP and zyxin, which collectively function to maintain an actin-α-actinin interaction as the fundamental association of the sarcomere. Aspects of abnormal heart development and the manifestation of a subset of muscular-based disease have previously been attributed to mutations in key structural proteins. Our study reveals an essential requirement for direct transcriptional regulation of sarcomere integrity, in the context of enabling foetal cardiomyocyte hypertrophy, maintenance of contractile function and progression towards inherited or acquired myopathic disease.</jats:p>

収録刊行物

  • Development

    Development 136 (3), 495-505, 2009-02-01

    The Company of Biologists

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ